Article Versions Notes

Muto V, Benigni F, Magliocca V, Borghi R, Flex E, Pallottini V, Rosa A, Compagnucci C, Tartaglia M. CRISPR/Cas9 and piggyBac Transposon-Based Conversion of a Pathogenic Biallelic TBCD Variant in a Patient-Derived iPSC Line Allows Correction of PEBAT-Related Endophenotypes. International Journal of Molecular Sciences. 2023; 24(9):7988. https://doi.org/10.3390/ijms24097988

Muto, Valentina, Federica Benigni, Valentina Magliocca, Rossella Borghi, Elisabetta Flex, Valentina Pallottini, Alessandro Rosa, Claudia Compagnucci, and Marco Tartaglia. 2023. "CRISPR/Cas9 and piggyBac Transposon-Based Conversion of a Pathogenic Biallelic TBCD Variant in a Patient-Derived iPSC Line Allows Correction of PEBAT-Related Endophenotypes" International Journal of Molecular Sciences 24, no. 9: 7988. https://doi.org/10.3390/ijms24097988

Muto, V., Benigni, F., Magliocca, V., Borghi, R., Flex, E., Pallottini, V., Rosa, A., Compagnucci, C., & Tartaglia, M. (2023). CRISPR/Cas9 and piggyBac Transposon-Based Conversion of a Pathogenic Biallelic TBCD Variant in a Patient-Derived iPSC Line Allows Correction of PEBAT-Related Endophenotypes. International Journal of Molecular Sciences, 24(9), 7988. https://doi.org/10.3390/ijms24097988